UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology

British journal of haematology, 2014-11, Vol.167 (4), p.453-465

2014

Volltextzugriff (PDF)

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing

Blood, 2019-06, Vol.133 (24), p.2559-2569

2019

Volltextzugriff (PDF)

Guideline on aspects of cancer‐related venous thrombosis

British journal of haematology, 2015-09, Vol.170 (5), p.640-648

2015

Volltextzugriff (PDF)

Endothelial von Willebrand factor regulates angiogenesis

Blood, 2011-01, Vol.117 (3), p.1071-1080

2011

Volltextzugriff (PDF)

Mapping the N-glycome of human von Willebrand factor

Biochemical journal, 2012-10, Vol.447 (2), p.217-228

2012

Volltextzugriff (PDF)

Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1331

2023

Volltextzugriff (PDF)

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

Angiogenesis (London), 2021-11, Vol.24 (4), p.755-788

2021

Volltextzugriff (PDF)

Guideline on the management of bleeding in patients on antithrombotic agents

British journal of haematology, 2013-01, Vol.160 (1), p.35-46

2013

Volltextzugriff (PDF)

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke

Stroke (1970), 2018-11, Vol.49 (11), p.2761-2763

2018

Volltextzugriff (PDF)

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial

Critical care (London, England), 2022-09, Vol.26 (1), p.290-12, Article 290

2022

Volltextzugriff (PDF)

Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype

Thrombosis research, 2021-01, Vol.197, p.100-108

2021

Volltextzugriff (PDF)

The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children

Transfusion (Philadelphia, Pa.), 2011-01, Vol.51 (1), p.62-70

2011

Volltextzugriff (PDF)

A novel method to quantify fibrin–fibrin and fibrin–α2-antiplasmin cross-links in thrombi formed from human trauma patient plasma

Journal of thrombosis and haemostasis, 2024-06, Vol.22 (6), p.1758-1771

2024

Volltextzugriff (PDF)

Associations of genetically determined iron status across the phenome: A mendelian randomization study

PLoS medicine, 2019-06, Vol.16 (6), p.e1002833-e1002833

2019

Volltextzugriff (PDF)

Coagulation status of critically ill patients with and without liver disease assessed using a novel thrombin generation analyzer

Journal of thrombosis and haemostasis, 2020-07, Vol.18 (7), p.1576-1585

2020

Volltextzugriff (PDF)

Von Willebrand factor, angiodysplasia and angiogenesis

Mediterranean journal of hematology and infectious diseases, 2013-09, Vol.5 (1), p.e2013060-e2013060

2013

Volltextzugriff (PDF)

A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF

Blood, 2009-09, Vol.114 (13), p.2819-2828

2009

Volltextzugriff (PDF)

Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study

Journal of the American Heart Association, 2021-04, Vol.10 (8), p.e019644

2021

Volltextzugriff (PDF)

Genetically Determined Platelet Count and Risk of Cardiovascular Disease

Arteriosclerosis, thrombosis, and vascular biology, 2018-12, Vol.38 (12), p.2862

2018

Volltextzugriff (PDF)

Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor

Blood, 2009-10, Vol.114 (16), p.3489-3496

2009

Volltextzugriff (PDF)

Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells

Blood, 2013-04, Vol.121 (14), p.2773-2784

2013

Volltextzugriff (PDF)

Drug therapy in anticoagulation: which drug for which patient?

Clinical medicine (London, England), 2017-06, Vol.17 (3), p.233-244

2017

Volltextzugriff (PDF)

New products for the treatment of haemophilia

British journal of haematology, 2016-01, Vol.172 (1), p.23-31

Laffan, Mike

2016

Volltextzugriff (PDF)

The Cost of Von Willebrand Disease in Europe: The CVESS Study

Clinical and applied thrombosis/hemostasis, 2022-08, Vol.28, p.107602962211205-10760296221120583

2022

Volltextzugriff (PDF)

Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

Haematologica (Roma), 2012-09, Vol.97 (9), p.1444-1444

2012

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(130)
Buchkapitel
(67)
Bücher
(4)
Berichte
(1)

Sprache

Englisch
(202)

Erscheinungsjahr

n.n

Thema

Hematology
(106)
Science & Technology
(103)
Life Sciences & Biomedicine
(102)
Humans
(76)
Haematology
(65)
Pathology
(31)
Cardiovascular System & Cardiology
(30)
Female
(28)
Peripheral Vascular Disease
(27)
Thrombosis
(27)
Male
(26)
Internal Medicine
(25)
Hematology, Oncology And Palliative Medicine
(23)
Bleeding
(19)
Middle Aged
(18)
Biological And Medical Sciences
(17)
Adult
(16)
Medical Sciences
(14)
Anticoagulants
(13)
Anticoagulants - Therapeutic Use
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing

Guideline on aspects of cancer‐related venous thrombosis

Endothelial von Willebrand factor regulates angiogenesis

Mapping the N-glycome of human von Willebrand factor

Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

Guideline on the management of bleeding in patients on antithrombotic agents

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial

Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype

The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children

A novel method to quantify fibrin–fibrin and fibrin–α2-antiplasmin cross-links in thrombi formed from human trauma patient plasma

Associations of genetically determined iron status across the phenome: A mendelian randomization study

Coagulation status of critically ill patients with and without liver disease assessed using a novel thrombin generation analyzer

Von Willebrand factor, angiodysplasia and angiogenesis

A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF

Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study

Genetically Determined Platelet Count and Risk of Cardiovascular Disease

Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor

Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells

Drug therapy in anticoagulation: which drug for which patient?

New products for the treatment of haemophilia

The Cost of Von Willebrand Disease in Europe: The CVESS Study

Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

Suchergebnisse filtern